IMPrimary immunisationInfant from 6 wk to <6 mth 2 doses 0.5 mL each w/ 1st dose given from 6 wk w/ 2 mth interval between doses. Unvaccinated infant from 6 mth to <12 mth 0.5 mL dose given from 6 mth. Adult, adolescent & childn from 12 mth 0.5 mL single dose. Booster vaccinationInfant from 6 wk to <6 mth Booster dose should be given at 12 mth after completion of primary immunisation course. Previously vaccinated infant from 6 mth to <12 mth Booster dose should be given at 12 mth w/ at least 2 mth interval after primary dose. Adult, adolescent & childn from 12 mth Booster dose is not routinely administered but may be given to subjects previously vaccinated w/ Nimenrix or other conjugated or plain polysaccharide meningococcal vaccines.
Not to be inj intravascularly, intradermally or SC. Not a substitute for tetanus immunization. Postpone vaccination in subjects w/ acute severe febrile illness. Thrombocytopenia or any coagulation disorder; syncope; anatomic or functional asplenia eg, sickle cell disease. Patients receiving immunosuppressants or w/ immunodeficiency; complement deficiencies & receiving treatment inhibiting terminal complement activation eg, eculizumab. Avoid injury from faints. Pregnancy & lactation.
Loss of appetite; irritability; drowsiness, headache; fever, inj site swelling, pain & redness, fatigue. GI symptoms eg, diarrhoea, vomiting, nausea; inj site haematoma.
J07AH08 - meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated ; Belongs to the class of meningococcal bacterial vaccines.
Sign Out
 (vial _ pre-filled syringe) 5 mcg_0.5 mL2f996b3a-59e8-4773-b3db-a5c600b50154.GIF)
